MANKIND.NS
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Acid Test Ratio: It has very strong liquidity, which means it can can cover its liabilities without relying on inventory

Inventory Turnover: Very Slow Inventory movement or over stocking risk

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Performance Graph
Financial Ratios
Ratio Value
PE Ratio59.84
Net Profit Margin0.19
Acid Test Ratio2.37
Inventory Turnover2.10
Coverage Ratio61.38
Debt to Equity0.02
Key Ratios

Net Profit Margin: Making high profit when compared with its revenue which generally means company’s strong hold in the market, and good efficiency of the business

Return on Assets: Very high efficiency of the assets which indicates assets are making high contribution to the revenue

Return on Equity: High income of the company when compared with its equity, which means efficient equity

Performance Graph
Profitability Ratios
Ratio Value
Net Profit Margin0.19
Return on Assets1.57
Return on Equity0.20
Performance Graph
Key Ratios

Acid Test Ratio: It has very strong liquidity, which means it can can cover its liabilities without relying on inventory

Current Ratio: It would not have any issues to cover its short-term liabilities because of strong liquidity

Performance Graph
Liquidity Ratios
Ratio Value
Acid Test Ratio2.37
Current Ratio3.10
Performance Graph
Key Ratios

Inventory Turnover: Very Slow Inventory movement or over stocking risk

Performance Graph
Efficiency Ratios
Ratio Value
Inventory Turnover2.10
Performance Graph
Key Ratios

Coverage Analysis: At a very strong financial position where company is easily able to pay its interest payments from its earnings (EBIT + Lease Payments)

Performance Graph
Coverage Ratios
Ratio Value
Coverage Ratio61.38
Performance Graph
Key Ratios

Debt to Equity Ratio: Company has low debt when compared to its equity which means it is financially stable

Interest Coverage Ratio: Company is at low risk of getting default as it can easily cover its interest payments and strong financial health

Performance Graph
Solvency Ratios
Ratio Value
Debt to Equity Ratio0.02
Interest Coverage Ratio84.90
Performance Graph
Key Ratios

P/E Ratio: Overvalued stock which means company is making very less revenue per share but stock price is very high which represent speculative stock

Dividend Yield: NA

Performance Graph
Market Ratios
Ratio Value
P/E Ratio59.84
Gross Profit Margin0.68
Price to Book Ratio12.23
Dividend Yield0.00
Performance Graph

Balance Sheet Analysis of Mankind Pharma Limited

The balance sheet in the financial statement of the company shows its financial position at a particular point in time.

It consists of the following:

  • Assets: Something that the company owns and that gives financial benefits over a period of time.
  • Liabilities: Something that a company owes and that has a financial burden on the company.
  • Equity: It is basically the owner’s share in the company.

The formula is:

Assets = Liabilities + Equity
đź“ŚAssets:
Asset
Value & Year
2024
2023
2022
Total Assets 119633000000 97154491000 91477400000
Total Non Current Assets 53950285000 53875771000 47409210000
Other Non Current Assets 662811000 - -
Non Current Prepaid Assets 842377000 874087000 866220000
Non Current Deferred Taxes Assets 803975000 297769000 392880000
Financial Assets - - -
Investment In Financial Assets 1217797000 1763476000 726530000
Held To Maturity Securities - - -
Available For Sale Securities 947578000 1475029000 456400000
Financial Assets Fair Value 270219000 288447000 270130000
Long Term Equity Investment 1892824000 1814112000 1677430000
Investments In Associates At Cost 1116967000 1035360000 1038220000
Goodwill And Other Intangible Assets 16830614000 17784394000 18946460000
Other Intangible Assets 16630389000 17584169000 18742040000
Goodwill 200225000 200225000 204420000
Net Ppe 31386868000 30169910000 23895930000
Accumulated Depreciation -9633912000 -7437303000 -5822370000
Gross Ppe 41020780000 37607213000 29718300000
Construction In Progress 2070939000 4931920000 6698730000
Other Properties 29315929000 - -
Machinery Furniture Equipment 21504218000 17352318000 13921070000
Buildings And Improvements 12791759000 10689634000 6014210000
Land And Improvements 4653864000 4633341000 3084290000
Properties - - -
Current Assets 65682262000 43278720000 44068190000
Other Current Assets 6916768000 - -
Hedging Assets Current - - -
Assets Held For Sale Current 27020000 33156000 29820000
Restricted Cash 695863000 70669000 10940000
Prepaid Assets 6676446000 6916109000 9391120000
Inventory 15534612000 14984582000 17602390000
Other Inventories - 410075000 425630000
Finished Goods 10006875000 9197616000 12001850000
Work In Process 997880000 860353000 940410000
Raw Materials 4529857000 4516538000 4234500000
Other Receivables 400546000 293932000 359170000
Taxes Receivable - - -
Accounts Receivable 8482812000 5764214000 3881660000
Allowance For Doubtful Accounts Receivable -282465000 -202444000 -110940000
Gross Accounts Receivable 8765277000 5966658000 3992600000
Cash Cash Equivalents And Short Term Investments 33864963000 15216058000 12793090000
Other Short Term Investments 30044888000 12167851000 9767750000
Cash And Cash Equivalents 3820075000 3048207000 3025340000
Cash Equivalents 1189598000 70108000 -
Cash Financial 2630477000 2978099000 3025340000
đź“Ś Liabilities & Equity
Liability/Equity
Value & Year
2024
2023
2022
Net Debt - - 5654940000
Total Debt 2071724000 1703709000 8730750000
Total Liabilities Net Minority Interest 23874666000 20921562000 28314320000
Total Non Current Liabilities Net Minority Interest 2677368000 2290200000 2079630000
Other Non Current Liabilities 229615000 - -
Derivative Product Liabilities - - -
Non Current Pension And Other Postretirement Benefit Plans 1231246000 978888000 800040000
Trade And Other Payables Non Current - - -
Non Current Deferred Revenue 229615000 254946000 201540000
Non Current Deferred Taxes Liabilities 890692000 773121000 556210000
Long Term Debt And Capital Lease Obligation 325815000 283245000 521840000
Long Term Capital Lease Obligation 77138000 51780000 29900000
Long Term Debt 248677000 231465000 491940000
Long Term Provisions 1231246000 - -
Current Liabilities 21197298000 18631362000 26234690000
Other Current Liabilities 1207327000 932455000 2057410000
Current Deferred Taxes Liabilities - - -
Current Debt And Capital Lease Obligation 1745909000 1420464000 8208910000
Current Capital Lease Obligation 34228000 25565000 20570000
Current Debt 1711681000 1394899000 8188340000
Pension And Other Post Retirement Benefit Plans Current - - -
Current Provisions 3893072000 3076304000 2645030000
Payables 12500126000 11554131000 11936150000
Other Payable 1006431000 1009807000 1021480000
Dividends Payable - - -
Total Tax Payable 463787000 462555000 150900000
Accounts Payable 11029908000 10081769000 10763770000
Common Stock Equity 93630881000 74352228000 61552290000
Total Capitalization 93879558000 74583693000 62044230000
Total Equity Gross Minority Interest 95757881000 76232929000 63163080000
Minority Interest 2127000000 1880701000 1610790000
Stockholders Equity 93630881000 74352228000 61552290000
Other Equity Interest 232456000 591000 -
Treasury Stock - - -
Retained Earnings 99188365000 80122020000 67351870000
Additional Paid In Capital 421174000 421174000 421170000
Capital Stock 400588000 400588000 400590000
Common Stock 400588000 400588000 400590000

Income statement interpretation for Mankind Pharma Limited

The income statement in the financial statement of the company shows its company financial performance over a period in time.

It consists of the following:

  • Revenue: It is the total amount of money earned from the core business activity of the company.
  • Expenses: It is the total amount required for running the full functionality of the company.
  • Profit or loss:In very simple terms, when a company pays its expenses using its revenue, then what’s left is profit, and in case expenses are more when compared with revenue, then it is loss.
đź“ŚRevenue & Profitability
Revenue/Profitability
Value & Year
2024
2023
2022
Total Revenue 103348000000 87494330000 77815550000
Operating Revenue 103348000000 87494330000 77815550000
Cost Of Revenue 32685501000 29623271000 24700080000
Gross Profit 70662245000 57871059000 53115470000
Ebitda 28262114000 20374322000 21969990000
Ebit 24279577000 17115127000 20303790000
Operating Income 22342940000 16372741000 18781310000
Net Income 19128967000 12818591000 14334750000
Net Income From Continuing Operation Net Minority Interest 19128967000 12818591000 14334750000
Net Income From Continuing And Discontinued Operation 19128967000 12818591000 14334750000
Net Income Common Stockholders 19128967000 12818591000 14334750000
Net Income Including Noncontrolling Interests 19417717000 13096758000 14529560000
Net Income Discontinuous Operations - - -
Net Income Continuous Operations 19417717000 13096758000 14529560000
Normalized Income 18199143616 12669988941 13609810408
Normalized Ebitda 27113191000 20184706000 20984750000
Total Unusual Items 1148923000 189616000 985240000
Total Unusual Items Excluding Goodwill 1148923000 189616000 985240000
đź“ŚExpenses & Taxes
Expenses/Taxes
Value & Year
2024
2023
2022
Reconciled Depreciation 3982537000 3259195000 1666200000
Reconciled Cost Of Revenue 32685501000 29623271000 24700080000
Total Expenses 81004806000 71121589000 59034240000
Operating Expense 48319305000 41498318000 34334160000
Other Operating Expenses 10871217000 11973642000 9585830000
Depreciation And Amortization In Income Statement 3982537000 3259195000 1666200000
Amortization 1623819000 1588347000 252160000
Depreciation Income Statement 2358718000 1670848000 1414040000
Selling General And Administration 9898227000 6690590000 6585810000
Selling And Marketing Expense 7290325000 4576131000 5338940000
General And Administrative Expense 2607902000 2114459000 1246870000
Rent And Landing Fees 232124000 204261000 212570000
Tax Provision 4575865000 3615633000 5216430000
Pretax Income 23993582000 16712391000 19745990000
Other Non Operating Income Expenses 213142000 251708000 215280000
Special Income Charges -186366000 -184694000 110910000
Other Special Charges -4801000 -16649000 37430000
Write Off 144253000 154266000 -148340000
Net Non Operating Interest Income Expense 50055000 -330004000 -468800000
Total Other Finance Cost 64460000 54909000 40230000
Interest Expense Non Operating 285995000 402736000 557800000
Interest Income Non Operating 400510000 127641000 129230000
đź“Ś Earnings Per Share
Earnings Per Share
Value & Year
2024
2023
2022
Diluted Eps 47.68 32.00 35.78
Basic Eps 47.75 32.00 35.78
Diluted Ni Avail To Com Stockholders 19128967000 12818591000 14334750000
Net Income From Continuing Operations 23993582000 16712391000 19745990000
Minority Interests -288750000 -278167000 -194810000

Cash flow analysis for Mankind Pharma Limited

The cashflow statement in the financial statement of the company shows how cash is moving in or moving out of the company over a period of time.

It consists of the following:

  • Operating activities: Cash flow from the core business operations.
  • Investing activities: Cashflow from investments made by the company.
  • Financing activities: These are cash from loans or by issuing shares or paying out dividends.
đź“ŚOperating Cash Flow
Operating Cash Flow
Value & Year
2024
2023
2022
Operating Cash Flow 21524450000 18133017000 9197760000
Changes In Cash 760203000 194449000 1552530000
Taxes Refund Paid -4795338000 -3230967000 -4995090000
Change In Working Capital 204159000 1667289000 -5861220000
Change In Other Current Liabilities 536256000 -441883000 1920160000
Change In Other Current Assets 1185657000 1662640000 -5921960000
Change In Payable 974521000 -650193000 4198190000
Change In Inventory -550030000 2617799000 -5767000000
Change In Receivables -2899102000 -2053148000 -659530000
Other Non Cash Items -835002000 -92688000 -277970000
Stock Based Compensation 231863000 591000 -
Provision And Write Off Of Assets 79596000 91504000 96530000
Depreciation And Amortization 3982537000 3259195000 1666200000
Amortization Cash Flow 1623819000 1588347000 252160000
Depreciation 2358718000 1670848000 1414040000
đź“ŚInvesting Cash Flow
Investing Cash Flow
Value & Year
2024
2023
2022
Investing Cash Flow -20816903000 -10541287000 -13691430000
Net Other Investing Changes -6675858000 -449711000 4301950000
Interest Received Cfi 400510000 127640000 129230000
Dividends Received Cfi 24000 24000 10000
Net Investment Purchase And Sale -10854938000 -1854220000 4921450000
Sale Of Investment 5448875000 7122427000 16779000000
Purchase Of Investment -16303813000 -8976647000 -11857550000
Net Business Purchase And Sale 73951000 -100715000 207030000
Sale Of Business - - 207450000
Purchase Of Business - -38273000 -420000
Net Ppe Purchase And Sale -3078265000 -7829726000 -4617160000
Sale Of Ppe 75070000 60479000 31500000
Purchase Of Ppe -3153335000 -7890205000 -4648660000
Net Intangibles Purchase And Sale -670033000 -430485000 -18806570000
Purchase Of Intangibles -670033000 -430485000 -18806570000
đź“Ś Financing Cash Flow
Financing Cash Flow
Value & Year
2024
2023
2022
Financing Cash Flow 52656000 -7397281000 6046200000
Net Other Financing Charges - - -
Interest Paid Cff -261736000 -419311000 -177870000
Cash Dividends Paid - - -
Common Stock Dividend Paid - - -
Net Common Stock Issuance - - -
Common Stock Payments - - -
Common Stock Issuance - - -
Repurchase Of Capital Stock - - -
Repayment Of Debt -3667411000 -17938231000 -6539420000
Issuance Of Debt 4007049000 10985799000 12781880000
Issuance Of Capital Stock - - -
Net Issuance Payments Of Debt 339638000 -6952432000 6242460000
Net Short Term Debt Issuance 348032000 -6694172000 6269770000
Short Term Debt Issuance 3746124000 10947348000 12723280000
Net Long Term Debt Issuance -8394000 -258260000 -27310000
Long Term Debt Payments -269319000 -296711000 -85910000
Long Term Debt Issuance 260925000 38451000 58600000
Net Preferred Stock Issuance - - -
Preferred Stock Payments - - -

Summary

Fundamental Overview of MANKIND.NS (Mankind Pharma Limited)

Above is the summary for fundamental analysis of Mankind Pharma Limited , whose ticker name is MANKIND.NS and belongs to sector Healthcare, and it is listed in NSE (National Stock Exchange).

The Mankind Pharma Limited which is listed in NSE (National Stock Exchange) has a PE ratio of 59.84, MANKIND.NS has a net profit margin of 0.19, the acid test ratio for MANKIND.NS is 2.37, MANKIND.NS has an inventory turnover of 2.10, and MANKIND.NS has debt-to-equity ratio of 0.02.

The MANKIND.NS whose company name is Mankind Pharma Limited has made profit/loss of 70662245000 with total revenue of 103348000000, MANKIND.NS has assets worth of 119633000000.

1. What is fundamental analysis?

Fundamental analysis is looking into a company’s real business performance by analyzing financial statements, earning reports, and key valuation ratios.

Basically, fundamental analysis involves examining a company’s revenue, profits, losses, debts, assets, liabilities, and ratios calculated using these values to determine long-term investment strategies.

Fundamental analysis may not work for short-term trading of stock; it is usually incorporated by long-term investors.

2. Importance of Fundamental Analysis

Imagine you are locking a good amount of funds into an unknown company for many years. Sounds stupid, right?

This is where fundamental analysis comes into the picture, which turns an unknown enemy into a known friend.

As fundamental analysis involves calculating how a company is actually performing, the real revenue, profits, assets, liabilities, debts, and more. This helps investors to determine what the actual current financial condition of the company is, how much the company’s stock price is justified when compared to earnings (Corporate earnings reports India) that it is making through business, what the probability is that the company will go bankrupt in the future, how much growth the company has shown in the past, and other financial ratios.

All these calculations and analyses determine the financial health of the company, historical business growth, company’s efficiency, and its stock price compared with real earnings (Corporate earnings reports India), which helps traders to make investment decisions for long-term investment strategies.

2. How to Use Our Tool

  • Search for the stock that you want to analyze in the search bar by typing the name of the company or ticker.
  • Once you land on the Stock Analytics Page, click on “Fundamental Analysis”; this will take you to the fundamental analysis page.
  • Apply Filter
  • On the “Fundamental Analysis” page, the first tab is for “Summary and Ratio,” where in the top section you can find the overall summary of the stock’s fundamental analysis, where on the leftmost side it has a textual summary, then in the middle a gauge chart that represents overall financial health, and then a list of important ratios.
  • Apply Filter
  • Then in the same “Summary and Ratio” tab, we have included a detailed analysis of stock in various aspects, which includes “Profitability Analysis,” “Liquidity Analysis,” “Efficiency Analysis,” “Coverage Analysis,” Solvency Analysis,” and “Market Analysis,” which divide the stock’s fundamentals into the above aspects and analyze each in the same format as for overall analysis, where the leftmost side has a textual summary, then in the middle a gauge chart that represents overall analysis of the particular section, and then a list of important ratios. Required for the particular analysis.
  • Apply Filter